BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells
- 3 August 2000
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 60 (6) , 831-837
- https://doi.org/10.1016/s0006-2952(00)00396-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Atypical Multidrug Resistance: Breast Cancer Resistance Protein Messenger RNA Expression in Mitoxantrone-Selected Cell LinesJNCI Journal of the National Cancer Institute, 1999
- A multidrug resistance transporter from human MCF-7 breast cancer cellsProceedings of the National Academy of Sciences, 1998
- Reduced cellular accumulation of topotecan: a novel mechanism of resistance in a human ovarian cancer cell lineBritish Journal of Cancer, 1998
- Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpressionJournal of Cellular Biochemistry, 1997
- Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoproteinInternational Journal of Cancer, 1997
- No Alteration in DNA Topoisomerase I Gene Related to CPT‐11 Resistance in Human Lung CancerJapanese Journal of Cancer Research, 1996
- Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecanBritish Journal of Cancer, 1995
- Cellular Determinants of Sensitivity and Resistance to DNA Topoisomerase InhibitorsCancer Investigation, 1994
- Cloning of Chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation responsible for camptothecin resistance.Journal of Biological Chemistry, 1993
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990